Search Results - "Everitt, Sarah"

Early Skeletal Muscle Loss in Non-Small Cell Lung Cancer Patients Receiving Chemoradiation and Relationship to Survival by Kiss, Nicole, Beraldo, Julian, Everitt, Sarah

“…Purpose Sarcopenia is associated with reduced survival in cancer. Currently, data on sarcopenia at presentation and muscle loss throughout treatment are…”
Get full text

Predicting Esophagitis After Chemoradiation Therapy for Non-Small Cell Lung Cancer: An Individual Patient Data Meta-Analysis by Palma, David A., MD, MSc, PhD, Senan, Suresh, MRCP, FRCR, PhD, Oberije, Cary, MSc, PhD, Belderbos, Jose, MD, PhD, Dios, Núria Rodríguez de, MD PhD, Bradley, Jeffrey D., MD, Barriger, R. Bryan, MD, Moreno-Jiménez, Marta, MD, PhD, Kim, Tae Hyun, MD, Ramella, Sara, MD, Everitt, Sarah, PhD, Rengan, Ramesh, MD, PhD, Marks, Lawrence B., MD, De Ruyck, Kim, PhD, Warner, Andrew, MSc, Rodrigues, George, MD, MSc

“…Purpose Concurrent chemoradiation therapy (CCRT) improves survival compared with sequential treatment for locally advanced non-small cell lung cancer, but it…”
Get full text

How often do cancer researchers make their data and code available and what factors are associated with sharing? by Hamilton, Daniel G, Page, Matthew J, Finch, Sue, Everitt, Sarah, Fidler, Fiona

“…Various stakeholders are calling for increased availability of data and code from cancer research. However, it is unclear how commonly these products are…”
Get full text

Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy by Wen, Shu Wen, Everitt, Sarah J, Bedő, Justin, Chabrot, Marine, Ball, David L, Solomon, Benjamin, MacManus, Michael, Hicks, Rodney J, Möller, Andreas, Leimgruber, Antoine

“…There is renewed interest in the immune regulatory role of the spleen in oncology. To date, very few studies have examined macroscopic variations of splenic…”
Get full text

Differential (18)F-FDG and (18)F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung Cancer by Everitt, Sarah J, Ball, David L, Hicks, Rodney J, Callahan, Jason, Plumridge, Nikki, Collins, Marnie, Herschtal, Alan, Binns, David, Kron, Tomas, Schneider, Michal, MacManus, Michael

“…We aimed to prospectively observe cellular metabolism and proliferation in patients with non-small-cell lung cancer (NSCLC) during radical chemoradiation…”
Get full text

Robust, independent and relevant prognostic 18F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any? by Konert, Tom, Everitt, Sarah, La Fontaine, Matthew D, van de Kamer, Jeroen B, MacManus, Michael P, Vogel, Wouter V, Callahan, Jason, Sonke, Jan-Jakob

“…In locally advanced lung cancer, established baseline clinical variables show limited prognostic accuracy and 18F-fluorodeoxyglucose positron emission…”
Get full text

Upright Radiation Therapy-A Historical Reflection and Opportunities for Future Applications by Rahim, Sulman, Korte, James, Hardcastle, Nicholas, Hegarty, Sarah, Kron, Tomas, Everitt, Sarah

“…Since the early days of megavoltage Radiation Therapy (RT), the potential of delivering treatment to a sub group of patients in an upright position has been…”
Get full text

What 18F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non–Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria? by Turgeon, Guy-Anne, Iravani, Amir, Akhurst, Tim, Beaulieu, Alexis, Callahan, Jason W, Bressel, Mathias, Cole, Aidan J, Everitt, Sarah J, Siva, Shankar, Hicks, Rodney J, Ball, David L, Mac Manus, Michael P

“…The optimal methodology for defining response with 18F-FDG PET after curative-intent chemoradiation for non–small cell lung cancer (NSCLC) is unknown. We…”
Get full text

PET-detected pneumonitis following curative-intent chemoradiation in non-small cell lung cancer (NSCLC): recognizing patterns and assessing the impact on the predictive ability of FDG-PET/CT response assessment by Iravani, Amir, Turgeon, Guy-Anne, Akhurst, Tim, Callahan, Jason W., Bressel, Mathias, Everitt, Sarah J., Siva, Shankar, Hofman, Michael S., Hicks, Rodney J., Ball, David L., Mac Manus, Michael P.

“…Purpose Inflammatory FDG uptake in the lung (PET-pneumonitis) following curative-intent radiotherapy (RT)/chemo-RT (CRT) in non-small cell lung cancer (NSCLC)…”
Get full text

Effect of Platinum-Based Chemoradiotherapy on Cellular Proliferation in Bone Marrow and Spleen, Estimated by (18)F-FLT PET/CT in Patients with Locally Advanced Non-Small Cell Lung Cancer by Leimgruber, Antoine, Möller, Andreas, Everitt, Sarah J, Chabrot, Marine, Ball, David L, Solomon, Ben, MacManus, Michael, Hicks, Rodney J

“…Historically, it has been difficult to monitor the acute impact of anticancer therapies on hematopoietic organs on a whole-body scale. Deeper understanding of…”
Get full text

A Deep Learning Model to Automate Skeletal Muscle Area Measurement on Computed Tomography Images by Amarasinghe, Kaushalya C, Lopes, Jamie, Beraldo, Julian, Kiss, Nicole, Bucknell, Nicholas, Everitt, Sarah, Jackson, Price, Litchfield, Cassandra, Denehy, Linda, Blyth, Benjamin J, Siva, Shankar, MacManus, Michael, Ball, David, Li, Jason, Hardcastle, Nicholas

“…Muscle wasting (Sarcopenia) is associated with poor outcomes in cancer patients. Early identification of sarcopenia can facilitate nutritional and exercise…”
Get full text

Please Place Your Seat in the Full Upright Position: A Technical Framework for Landing Upright Radiation Therapy in the 21st Century by Hegarty, Sarah, Hardcastle, Nicholas, Korte, James, Kron, Tomas, Everitt, Sarah, Rahim, Sulman, Hegi-Johnson, Fiona, Franich, Rick

“…Delivering radiotherapy to patients in an upright position can allow for increased patient comfort, reduction in normal tissue irradiation, or reduction of…”
Get full text

Distribution of Proliferating Bone Marrow in Adult Cancer Patients Determined Using FLT-PET Imaging by Hayman, James A., M.D., M.B.A, Callahan, Jason W., B.App.Sci., Med. Rad. (N.M.T.), Herschtal, Alan, B.Sc., B.E., Post.Grad. Dipl. (Appl. Stat.), Everitt, Sarah, B.App.Sci., Med. Rad. (R.T.), Binns, David S., Dip.App.Sci, Hicks, Rod J., M.D., F.R.A.C.P, Mac Manus, Michael, M.D., F.R.A.N.Z.C.R

“…Purpose Given that proliferating hematopoietic stem cells are especially radiosensitive, the bone marrow is a potential organ at risk, particularly with the…”
Get full text

Blood-Derived Extracellular Vesicle-Associated miR-3182 Detects Non-Small Cell Lung Cancer Patients by Visan, Kekoolani S, Lobb, Richard J, Wen, Shu Wen, Bedo, Justin, Lima, Luize G, Krumeich, Sophie, Palma, Carlos, Ferguson, Kaltin, Green, Ben, Niland, Colleen, Cloonan, Nicole, Simpson, Peter T, McCart Reed, Amy E, Everitt, Sarah J, MacManus, Michael P, Hartel, Gunter, Salomon, Carlos, Lakhani, Sunil R, Fielding, David, Möller, Andreas

“…With five-year survival rates as low as 3%, lung cancer is the most common cause of cancer-related mortality worldwide. The severity of the disease at…”
Get full text

Reproducibility of “Intelligent” Contouring of Gross Tumor Volume in Non–Small-Cell Lung Cancer on PET/CT Images Using a Standardized Visual Method by Bayne, Michael, D.M., F.R.C.R, Hicks, Rodney J., M.D., F.R.A.C.P, Everitt, Sarah, B.App.Sci., Med.Rad. (R.T.), Fimmell, Natalie, B.App.Sci., Med.Rad. (R.T.), Ball, David, M.D., F.R.A.N.Z.C.R, Reynolds, John, Ph.D, Lau, Eddie, F.R.A.N.Z.C.R, Pitman, Alex, M.D., F.R.A.N.Z.C.R, Ware, Robert, F.R.A.C.P, MacManus, Michael, M.D., F.R.A.N.Z.C.R

“…Purpose Positron emission tomography/computed tomography (PET/CT) is increasingly used for delineating gross tumor volume (GTV) in non–small-cell lung cancer…”
Get full text

Imaging immunity in patients with cancer using positron emission tomography by Hegi-Johnson, Fiona, Rudd, Stacey, Hicks, Rodney J., De Ruysscher, Dirk, Trapani, Joseph A., John, Thomas, Donnelly, Paul, Blyth, Benjamin, Hanna, Gerard, Everitt, Sarah, Roselt, Peter, MacManus, Michael P.

“…Immune checkpoint inhibitors and related molecules can achieve tumour regression, and even prolonged survival, for a subset of cancer patients with an…”
Get full text

Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy Planning by Campbell, Belinda A., MBBS, MMed, FRANZCR, Callahan, Jason, BApplSc(MedRad), Bressel, Mathias, BSc(Stats), Simoens, Nathalie, BSc(Med), Everitt, Sarah, BApplSci(MedRad), PhD, Hofman, Michael S., MBBS, FRACP, FAANMS, Hicks, Rodney J., MBBS, MD, FRACP, Burbury, Kate, MB, BS, DPhil, FRACP, FRCPA, MacManus, Michael, MBBCh, BAO, MD, MRCP, FRANZCR

“…Purpose Proliferating bone marrow is exquisitely sensitive to ionizing radiation. Knowledge of its distribution could improve radiation therapy planning to…”
Get full text

An epithelial-to-mesenchymal transition induced extracellular vesicle prognostic signature in non-small cell lung cancer by Lobb, Richard J., Visan, Kekoolani S., Wu, Li-Ying, Norris, Emma L., Hastie, Marcus L., Everitt, Sarah, Yang, Ian A., Bowman, Rayleen V., Siva, Shankar, Larsen, Jill E., Gorman, Jeffrey J., MacManus, Michael, Leimgruber, Antoine, Fong, Kwun M., Möller, Andreas

“…Despite significant therapeutic advances, lung cancer remains the leading cause of cancer-related death worldwide 1 . Non-small cell lung cancer (NSCLC)…”
Get full text

Predicting muscle loss during lung cancer treatment (PREDICT): protocol for a mixed methods prospective study by Kiss, Nicole K, Denehy, Linda, Edbrooke, Lara, Prado, Carla M, Ball, David, Siva, Shankar, Abbott, Gavin, Ugalde, Anna, Fraser, Steve F, Everitt, Sarah, Hardcastle, Nicholas, Wirth, Andrew, Daly, Robin M

“…IntroductionLow muscle mass and low muscle attenuation (radiodensity), reflecting increased muscle adiposity, are prevalent muscle abnormalities in people with…”
Get full text

The Evolving Role of Molecular Imaging in Non–Small Cell Lung Cancer Radiotherapy by MacManus, Michael, MD, FRANZCR, Everitt, Sarah, PhD, Hicks, Rodney J., MD, FRACP

“…Molecular imaging with positron emission tomography (PET) has dramatically changed the management of patients with lung cancer who are treated with…”
Get full text